M&A-led growth, $1B+ backlog and data center demand—plus margin, cash flow and leverage risks. Click for more on FPS stock.

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

According to Pranav Haldea, Managing Director of PRIME Database Group, the IPO pipeline remains staggering. As of now, 96 companies proposing to raise around ₹1.25 lakh crore have already secured SEBI ...

After euphoric listings and sharp corrections, can India’s IPO market recalibrate valuations, protect retail capital, and ...

Taken together, consumer discretionary and financial services raised roughly ₹1.12 lakh crore in 2025, accounting for around ...

Rs 1.75 lakh crore raised, but it also killed the "quick flip." With average listing gains crashing from 30% to just 9%, retail investors are fleeing. Yet, a massive 326% return secret is hidden in ...

IPO route during the year, mobilising Rs 1,75,901 crore — around 10 percent higher than the previous peak recorded in 2024.

India's IPO market, with 365 IPOs raising ₹1.95 trillion. Despite strong fundraising, few IPOs yielded significant returns for retail investors. Anondita Medicare led with a 601% return.

Medline MDLN, a private equity-backed medical-surgical products provider, went public Tuesday in the largest IPO of the year, drawing strong investor demand. The Northfield, Il.-based company raised ...

Market watchers flag over Rs 2.65 lakh crore pipeline, strong domestic investor support and regulatory tweaks, while warning that valuations, global cues and listing gains remain key risks ...

Even as concerns are being raised from various corners about the fact that IPOs are now becoming a tool for OFS and providing exit to existing investors and dilution to promoters, market experts say ...